Structure and function of steroid dehydrogenases involved in hypertension, fertility, and cancer

Steroids

Volumn 62, Issue 1, 1997, Pages 95-100

  Duax, William L ^a   Ghosh, Debashis ^b  

^a HAUPTMAN WOODWARD MEDICAL RESEARCH INSTITUTE   (United States)

^b ROSWELL PARK CANCER INSTITUTE   (United States)

Author keywords

11 hydroxysteroid dehydrogenase; 17 hydroxysteroid dehydrogenase; glycyrrhizic acid; short chain dehydrogenase reductase (SDR) enzyme; X ray crystal structure

Indexed keywords

11BETA HYDROXYSTEROID DEHYDROGENASE; 3ALPHA(OR 20BETA) HYDROXYSTEROID DEHYDROGENASE; ESTRADIOL; GLYCYRRHIZIC ACID; STEROID REDUCTASE; TESTOSTERONE 17BETA DEHYDROGENASE;

CANCER; CONFERENCE PAPER; CRYSTAL STRUCTURE; ENZYME CHEMISTRY; ENZYME STRUCTURE; FERTILITY; HUMAN; HYPERTENSION; STEROID METABOLISM; STRUCTURE ACTIVITY RELATION;

BACTERIA (MICROORGANISMS); GLYCYRRHIZA; INSECTA; MAMMALIA;

EID: 0031030591     PISSN: 0039128X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0039-128X(96)00166-3     Document Type: Conference Paper

References (26)

1. Jörnvall H, Persson B, Krook M, Atrian S, Gonzàlez-Duarte, Jeffery J, Ghosh D (1995). Short-chain dehydrogenase/reductases (SDR). Biochemistry 34:6003-6013.
2. Birkttoft JJ, Banaszak LJ (1984). Peptide and Protein Review, Vol. 4, Milton T. W. Hearn (ed), Marcel Dekker, New York, pp. 1-44.
3. Watson HC, Banaszak LJ (1964). Structure of glyceraldehyde-3-phosphate dehydrogenase. Nature 204:918-920.
4. Adams MJ, Ford GC, Koekock R, Lentz PJ, Jr, McPherson A Jr, Rossmann MG, Smiley IE (1970). Structure of lactate dehydrogenase at 2.8 Å resolution. Nature 227:1098-1103.
5. Hill E, Tsernoglau D, Webb L, Banaszak LJ (1972). Polypeptide conformation of cytoplasmic maleate dehydrogenase from an electron density map at 3.0 Å resolution. J Mol Biol 72:577-589.
6. Ghosh D, Wawrzak Z, Weeks CM, Duax WL, Erman M (1994). The refined three-dimensional structure of 3α,20β-hydroxysteroid dehydrogenase and possible roles of the residues conserved in "short-chain" dehydrogenases. Structure 2:629-640.
7. Varughese KI, Skinner MM, Whiteley JM, Matthews DA, Xuong NH (1992). Crystal structure of rat liver dihydropteridine reductase. Proc Natl Acad Sci USA 89:6080-6084.
8. Tanaka N, Nonaka T, Nakanishi M, Deyashiki Y, Hara A, Mitsui Y (1996). Crystal structure of the ternary complex of mouse lung carbonyl reductase at 1.8 Å resolution: the structural origin of co-enzyme specificity in the short-chain dehydrogenase/reductase family. Structure 4:33-45.
9. Tanaka N, Nonaka T, Tanabe T, Yashimoto T, Tsuru D, Mitsui Y (1996). Crystal structures of the binary and ternary complexes of 7α-hydroxysteroid dehydrogenase from E. coli. Biochemistry (in press).
10. Ghosh D, Pletnev VZ, Zhu D-W, Wawrzak Z, Duax WL, Pangborn W, Labrie F, Lin S-X (1995). Structure of human estrogenic 17β-hydroxysteroid dehydrogenase at 2.20 Å resolution. Structure 3: 503-513.
11. Sweet F, Samant BR (1980). Bifunctional enzyme activity at the same active site: study of 3α and 20β activity by affinity alkylation of 3α,20β-hydroxysteroid dehydrogenase with 17-(bromoacetoxy) steroids. Biochemistry 19:978-986.
12. Betz G, Warren JC (1968). Reaction mechanism and stereospecificity of 20β-hydroxysteroid dehydrogenase. Arch Biochem Biophys 128:745-752.
13. Chen Z, Jiang JC, Lin Z-G, Lee WR, Baker ME, Chang SH (1993). Site specific mutagenesis of Drosophila alcohol dehydrogenase evidence for involvement of tyrosine-152 and lysine-156 in catalysis. Biochemistry 32:3342-3346.
14. 5. Crystal Struct Commun 1:13-15.
15. Baker ME (1991). Evolution of enzymatic regulation of prostaglandin action: novel connections to regulation of human sex and adrenal function, antibiotic synthesis and nitrogen fixation. Prostaglandins 42:391-410.
16. Gierero RJ, Rassaert CL, DiPasquale G, Kroc RL (1958). Endocrine involvement in licorice hypertension. Am J Physiol 194:241-245.
17. Duaz WL, Griffin JF (1990). Molecular structure, receptor binding and activity of sex steroids. In: Jensen B, Jorgensen FS, Kofod H (eds), Frontiers in Drug Research. Crystallographic and Computational Methods. Munksgaard, Copenhagen, pp. 62-74.
18. Ulick S, Levine LS, Gunczler P, Zanconato G, Ramirez LC, Rauh W, Rosler A, Bradlow HL, New MI (1979). A syndrome of apparent mineralocorticoid excess associated with defects in the peripheral metabolisms of cortisol. J Clin Endocrinol Metab 49:757.
19. New MI, Oberfield SE, Carey R, Greig F, Ulick S, Levind LS (1982). A genetic defect in cortisol metabolisms as the basis for the syndrome of apparent mineralocorticoid excess. In: Mantero F, Biglieri E, Edwards CRW (eds), Serono Symposium No. 50, Endocrinology of Hypertension, Academic Press, London, pp. 85-101.
20. Monder C, Stewart PM, Lakshmi V, Valentino R, Burt D, Edwards CRW (1989). Licorice inhibits corticosteroid dehydrogenase of rat kidney and liver: in vivo and in vitro studies. Endocrinology 125: 1046-1053.
21. Ghosh D, Erman M, Pangborn W, Duax WL, Baker ME (1992). Inhibition of Streptomyces hydrogenans 3α,20β-hydroxysteroid dehydrogenase by licorice-derived compounds and crystallization of an enzyme-cofactor-inhibitor complex. J Steroid Biochem Mol Biol 42:849-853.
22. Ghosh D, Erman M, Wawrzak Z, Duax WL, Pangborn W (1994). Mechanism of inhibition of 3α,20β-hydroxysteroid dehydrogenase by a licorice-derived steroidal inhibitor. Structure 2:973-980.
23. Dickson RB, Lippman ME (1987). Estrogenic regulation of growth and polypeptide growth factor secretion in human breast carcinoma. Endocr Rev 8:29-43.
24. Horwitz KB, McGuire WL (1987) Nuclear mechanisms of estrogen action. Effects of estradiol and anti-estrogens on estrogen receptors and nuclear receptor processing. J Biol Chem 253:8185-8191.
25. Labrie C, Martel C, Dufour J-M, Levesque C, Merand Y, Labrie F (1992). Novel compounds inhibit estrogen formation and action. Cancer Res 52:610-615.
26. Puranen TJ, Poutanen MH, Peltoketo HE, Vihko PT, Vihko RK (1994). Site-directed mutagenesis of the putative active site of human 17β-hydroxysteroid dehydrogenase type 1. Biochem J 304: 289-293.